15.1 C
New York
Friday, September 29, 2023

An Evaluation Of Boston Scientific Corporation (NYSE: BSX) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Boston Scientific Corporation (BSX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.36, or -0.67%, to $53.51. The Boston Scientific Corporation has recorded 246,597 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

BSX belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $53.87 and fluctuated between $54.41 as its day high and $53.54 as its day low. The current market capitalization of Boston Scientific Corporation is $78.91B. A total of 4.42 million shares were traded on the day, compared to an average of 7.14M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, BSX has seen 10 BUY and 8 SELL insider trades, representing the acquisition of 24,006 and the disposition of 55,890 shares. Over the last 12 months, there were 101 BUYs and 108 SELLs from insiders. Insiders purchased 907,310 shares during that period but sold 1,036,985.

In the most recent transaction, Mirviss Jeffrey B. sold 4,657 shares of BSX for 54.50 per share on Aug 29. After the transaction, the EVP&Pres, Periph Intervent now owns 60,588 company shares. In a previous transaction on Aug 28, Mirviss Jeffrey B. sold 13,971 shares at 53.14 per share. BSX shares that EVP&Pres, Periph Intervent owns now total 65,245.

Among the insiders who sold shares, Brown Vance R disposed of 15,750 shares on Aug 25 at a per-share price of $50.52. This resulted in the SVP, GC and Corp. Secretary holding 28,578 shares of BSX after the transaction. In another insider transaction, Butcher Arthur C sold 6,600 shares at $50.40 per share on Aug 21. Company shares held by the EVP& Grp Pres, MedSurg & APAC now total 11,396.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for BSX in the last 3 months, the mean price target is $60.50 with high estimates of $68.00 and low estimates of $55.00. In terms of 52-week highs and lows, BSX has a high of $54.99 and a low of $37.74.

As of this writing, BSX has an earnings estimate of $0.48 per share for the current quarter. EPS was calculated based on a consensus of 26 estimates, with a high estimate of $0.49 per share and a lower estimate of $0.47. The company reported an EPS of $0.47 in the last quarter, which was 6.80% higher than expectations of $0.44.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $12.60, while its Total Shareholder’s Equity was $16.62B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.52.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles